Dr. Emil Tsai, M.D., Ph.D., M.A.S. is a renowned scientist, professor at UCLA School of Medicine, and the founder of SyneuRx, a clinical-stage global biotech company focused on the development of new classes of drugs for COVID-19 and multiple major central nervous system disorders.
